GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acticor Biotech SA (XPAR:ALACT) » Definitions » Short-Term Capital Lease Obligation

Acticor Biotech (XPAR:ALACT) Short-Term Capital Lease Obligation : €1.93 Mil (As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Acticor Biotech Short-Term Capital Lease Obligation?

Acticor Biotech's Short-Term Capital Lease Obligation for the quarter that ended in Jun. 2023 was €1.93 Mil.

Acticor Biotech's quarterly Short-Term Capital Lease Obligation declined from Jun. 2022 (€0.02 Mil) to Dec. 2022 (€0.00 Mil) but then increased from Dec. 2022 (€0.00 Mil) to Jun. 2023 (€1.93 Mil).

Acticor Biotech's annual Short-Term Capital Lease Obligation declined from Dec. 2020 (€0.06 Mil) to Dec. 2021 (€0.05 Mil) and declined from Dec. 2021 (€0.05 Mil) to Dec. 2022 (€0.00 Mil).

Acticor Biotech Short-Term Capital Lease Obligation Historical Data

The historical data trend for Acticor Biotech's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acticor Biotech Short-Term Capital Lease Obligation Chart

Acticor Biotech Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Short-Term Capital Lease Obligation
Get a 7-Day Free Trial 0.05 0.06 0.06 0.05 -

Acticor Biotech Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Short-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only 0.06 0.05 0.02 - 1.93

Acticor Biotech Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Acticor Biotech Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Acticor Biotech's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Acticor Biotech (XPAR:ALACT) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acticor Biotech SA (XPAR:ALACT) » Definitions » Short-Term Capital Lease Obligation
Comparable Companies
XPAR:ALCLS XPAR:ABNX XPAR:ALGEN XPAR:GNRO XPAR:ALVIO XPAR:PHXM XPAR:ALDVI XPAR:SIGHT XPAR:ALCOX XPAR:ALVAL OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
7V7:Germany
Address
82 Avenue du Maine, Wojo Building, Paris, FRA, 75014
Website
https://www.acticor-biotech.com
Acticor Biotech SA is a clinical stage biopharmaceutical company. It is developing a treatment for cardiovascular emergencies, with a primary focus on Acute Ischemic Stroke.

Acticor Biotech (XPAR:ALACT) Headlines

No Headlines